Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

about

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

Item

http://www.wikidata.org/entity/Q51823725

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@en

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@nl

type

Item

label

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@en

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@nl

prefLabel

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@en

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.

@nl

P1154

2-s2.0-85030169157

http://www.w3.org/2001/XMLSchema#string

P1433

Journal of Thrombosis and Haemostasis

P1476

Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease

@en

P2093

A Gils

http://www.w3.org/2001/XMLSchema#string

A Johnson

http://www.w3.org/2001/XMLSchema#string

D J Scott

http://www.w3.org/2001/XMLSchema#string

H Philippou

http://www.w3.org/2001/XMLSchema#string

J Zhong

http://www.w3.org/2001/XMLSchema#string

K I Bridge

http://www.w3.org/2001/XMLSchema#string

L Bollen

http://www.w3.org/2001/XMLSchema#string

M Hesketh

http://www.w3.org/2001/XMLSchema#string

R A S Ariёns

http://www.w3.org/2001/XMLSchema#string

P2860

Pro-carboxypeptidase R cleaves bradykinin following activation

Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms.

Diabetes and the abdominal aortic aneurysm.

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.

Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening.

Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.

Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.

Effect of intraluminal thrombus on wall stress in patient-specific models of abdominal aortic aneurysm.

The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.

Polyphosphate modulates blood coagulation and fibrinolysis.

P304

2218-2225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JTH.13804

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fraser L Macrae

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28834317

http://www.w3.org/2001/XMLSchema#string

P953

120480/